A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study of the Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Healthy Subjects

Trial Profile

A Phase 1 Randomized, Placebo-controlled, Single and Multiple Ascending Dose Study of the Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2018

At a glance

  • Drugs AG 10 (Primary)
  • Indications Amyloidosis
  • Focus Adverse reactions; First in man
  • Sponsors Eidos Therapeutics
  • Most Recent Events

    • 07 Aug 2018 According to an Eidos Therapeutics media release, complete data will be presented at poster presentation at Heart Failure Society of America 22nd Annual Scientific Meeting in September 2018.
    • 03 May 2018 According to an Eidos Therapeutics media release, results from this trial were presented at the 16thInternational Symposium on Amyloidosis 2018.
    • 03 May 2018 According to an Eidos Therapeutics media release, status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top